Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 113

Results For "expansion"

1193 News Found

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare
interviews | October 20, 2021

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare

Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.

Pharma exports continue to climb in H1FY22
News | October 19, 2021

Pharma exports continue to climb in H1FY22

Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline
Biotech | October 18, 2021

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline

Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme

AUM Biosciences closes US $ 27 million `Series A’ funding round
Startup | October 15, 2021

AUM Biosciences closes US $ 27 million `Series A’ funding round

Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate

IOL receives Korean FDA approval
Drug Approval | October 14, 2021

IOL receives Korean FDA approval

The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead

Lonza to expand development services for mammalian products in Singapore
Biotech | October 13, 2021

Lonza to expand development services for mammalian products in Singapore

This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites

Tarsons earmarks funds from IPO to double capacity at its Panchla facility
News | October 12, 2021

Tarsons earmarks funds from IPO to double capacity at its Panchla facility

An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion

LSNE expands lyophilization capacity at Madison, USA
Biotech | October 12, 2021

LSNE expands lyophilization capacity at Madison, USA

This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site

Everest Organics develops API for molnupiravir
News | October 12, 2021

Everest Organics develops API for molnupiravir

The drug is being developed at lab scale for the first-line of treatment of Covid-19

Sai Life Sciences presents its midterm report
News | October 11, 2021

Sai Life Sciences presents its midterm report

The company has enabled a transformation across three core areas with an investment target of US $ 150 million

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?

Latest Stories

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

Datroway wins US nod in aggressive breast cancer subtype

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India
Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India
With 14 acquisitions under our belt in last 5 years, we are ready for more: Pradeep Nair, Managing Director - India, Cole-Parmer
With 14 acquisitions under our belt in last 5 years, we are ready for more: Pradeep Nair, Managing Director - India, Cole-Parmer
Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
Dr Vidya Veldore Vice President, Clinical Operations, 4baseCare

Packaging